Delivery Order SPE2DB20D1004-SPE2DB24FF7R6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.95 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $27,472.38 firm fixed-price delivery order contract is for the supply of Advair HFA 115-21 MCG Inhaler, a prescription medication. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,635.56 Firm Fixed Price delivery order is for the supply of Advair HFA 115-21 MCG inhalers, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,131.32 delivery order contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price pricing type and a completion date of May 1, 2024. Amerisourcebergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,567.53 firm fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler, a medication used to treat asthma and chronic obstructive pulmonary disease. The contract has a completion date of November 22, 2024 and was awarded on November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,297.24 firm fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The contract has a completion date of July 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,207.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler (12GM), a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm-fixed-price delivery order with an ultimate completion date of August 15, 2024. Amerisourcebergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,258.23 firm-fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,201.15 firm fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,346.71 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhalers, with an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF7R6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,085.36 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA). The contract is for the supply of Advair HFA 230-21 MCG inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease. The contract has an ultimate completion date of April 8, 2024 and was awarded on April 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/5/24 |